CAS RN: 15802-00-3
Tetrabutylammonium Dibromoiodide
Product Availability
Choose a grade to view its available package options.
3 package records3 with current stock1 grade group
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20250616 |
10g |
In stock |
Shenzhen, Tianjin | Inquiry |
| Batchno.20260428 |
1g |
In stock |
Shanghai, Tianjin | Inquiry |
| Batchno.20250322 |
5g |
In stock |
Shanghai, Shenzhen, Tianjin, Wuhan, Chengdu | Inquiry |
-
Product code:
ICTT1269
-
Purity/Analytical Methods:
>97.0%(T)
GET A QUOTE
15802-00-3 / Tetrabutylammonium Dibromoiodide
Standard CAS: 15802-00-3
Multi CAS: No
Basic Information
CAS
15802-00-3
Multi CAS
No
Molecular Formula
C16H36Br2IN
Molecular Weight
529.200000
Exact Mass
529.023870
SMILES
CCCC[N+](CCCC)(CCCC)CCCC.Br[I-]Br
InChI
InChI=1S/C16H36N.Br2I/c1-5-9-13-17(14-10-6-2,15-11-7-3)16-12-8-4;1-3-2/h5-16H2,1-4H3;/q+1;-1
InChIKey
LFZGDXLUTJIZAG-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
20
Fraction Csp3
1
Rotatable bonds
12
H-bond acceptors
1
Molar refractivity
97.21
TPSA
0.0000
LogP / Solubility
WLOGP
3.7
MLOGP
3.29
XLogP3
3.7
Consensus LogP
3.56
Log S (ESOL)
-4.66
Class (ESOL)
Slightly soluble
Log S (Ali)
-6.57
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-7.61
Class (SILICOS-IT)
Insoluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
No
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-3.32
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
No
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
1.5
Safety & Transport
Pictogram(s)
Irritant
Signal
Warning
GHS Hazard Statements
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
Precautionary Statement Codes
P264, P264+P265, P280, P302+P352, P305+P351+P338, P321, P332+P317, P337+P317, and P362+P364